Squarepoint’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,866
Closed -$51.7K 4525
2025
Q4
$51.7K Buy
+11,866
New +$64.1K ﹤0.01% 4126
2025
Q3
Sell
-58,574
Closed -$168K 4588
2025
Q2
$168K Buy
58,574
+10,152
+21% +$26.8K ﹤0.01% 4031
2025
Q1
$131K Buy
48,422
+31,563
+187% +$118K ﹤0.01% 4139
2024
Q4
$39.8K Sell
16,859
-9,798
-37% -$26.1K ﹤0.01% 4876
2024
Q3
$63.2K Sell
26,657
-11,607
-30% -$25.6K ﹤0.01% 3954
2024
Q2
$74.6K Buy
+38,264
New +$130K ﹤0.01% 3851

Other funds holding GNLX

Squarepoint's GNLX Position: Q1 2026 in Review

Squarepoint sold out of Genelux (GNLX) in Q1 2026, closing a stake of 11,866 shares — an estimated $51.7K sold.

Squarepoint first reported a position in GNLX in Q2 2024 and held it in 6 quarters. The position peaked at $168K in Q2 2025. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Squarepoint reported no remaining Genelux position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 11,866 Genelux shares in Q1 2026, an estimated $51.7K.
  • Squarepoint first reported a position in Genelux in Q2 2024 and held it in 6 quarters.
  • Squarepoint's Genelux position peaked at $168K in Q2 2025.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.